COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,796 Articles (22,527 medRxiv, 8,269 bioRxiv)

Most recent first Previous |  Page 1551: Articles 15501-15510  | Next

Immune Correlates of Protection by mRNA-1273 Immunization against SARS-CoV-2 Infection in Nonhuman Primates
Corbett, K. S., Nason, M., Flach, B., Gagne, M., O'Connell, S., Johnston, T., Shah, S. N., Edara, V. V., Floyd, K., Lai, L., McDanal, C., Francica, J., Flynn, B., Wu, K., Choi, A., Koch, M., Abiona, O. M., Werner, A. P., Alvarado, G. S., Andrew, S. F., Donaldson, M. M., Fintzi, J., Flebbe, D., Lamb, E., Noe, A., Nurmukhambetova, S., Provost, S., Cook, A., Dodson, A., Faudree, A., Greenhouse, J., Kar, S., Pessaint, L., Porto, M., Steingrebe, K., Valentin, D., Zouantcha, S., Bock, K., Mahnaz, M., Nagata, B., Moliva, J. I., van de Wetering, R., Boyoglu-Barnum, S., Leung, K., Shi, W., Yang, E. S., Zhang, Y., Todd, J.-P., Wang, L., Andersen, H., Foulds, K. E., Edwards, D. K., Mascola, J. R. K., Moore, I. N., Lewis, M. G., Carfi, A., Montefiori, D., Suthar, M., McDermott, A., Sullivan, N., Roederer, M., Doueck, D., Graham, B. S., Seder, R. S.
10.1101/2021.04.20.440647 — Posted: 2021-04-21
Deep time course proteomics of SARS-CoV and SARS-CoV-2-infected human lung epithelial cells (Calu-3) reveals strong induction of interferon-stimulated gene (ISG) expression by SARS-CoV-2 in contrast to SARS-CoV
Grossegesse, M., Bourquain, D., Neumann, M., Schaade, L., Nitsche, A., Doellinger, J.
10.1101/2021.04.21.440783 — Posted: 2021-04-21
GIVE Statistic for Goodness of Fit in Instrumental Variables Models with Application to COVID Data
Dhar, S. S., Shalabh
10.1101/2021.04.18.440376 — Posted: 2021-04-21
Recognition of Divergent Viral Substrates by the SARS-CoV-2 Main Protease
MacDonald, E. A., Frey, G., Namchuk, M., Harrison, S. C., Hinshaw, S. M., Windsor, I. W.
10.1101/2021.04.20.440716 — Posted: 2021-04-21
Prediction of COVID-19 cases during Tokyo's Olympic and Paralympic Games
Tokuda, Y., Kuniya, T.
10.1101/2021.04.21.21255676 — Posted: 2021-04-21
Comparative Analysis of Emerging B.1.1.7+E484K SARS-CoV-2 isolates from Pennsylvania
Moustafa, A. M., Bianco, C., Denu, L., Ahmed, A., Neide, B., Everett, J., Reddy, S., Rabut, E., Deseignora, J., Feldman, M. D., Rodino, K. G., Bushman, F., Harris, R. M., Mell, J. C., Planet, P. J.
10.1101/2021.04.21.440801 — Posted: 2021-04-21
When can we safely return to normal? A novel method for identifying safe levels of NPIs in the context of COVID-19 vaccinations
Bianchin, G., Dall'Anese, E., Poveda, J. I., Buchwald, A.
10.1101/2021.04.20.21255350 — Posted: 2021-04-21
Discrete immune response signature to SARS-CoV-2 mRNA vaccination versus infection
Ivanova, E. N., Devlin, J. C., Buus, T. B., Koide, A., Cornelius, A., Samanovic, M. I., Herrera, A., Zhang, C., Desvignes, L., Odum, N., Ulrich, R., Mulligan, M. J., Koide, S., Ruggle, K. V., Herati, R. S., Koralov, S. B.
10.1101/2021.04.20.21255677 — Posted: 2021-04-21 Discussion: Onsite
Effectiveness of the BNT162b2 vaccine in preventing COVID-19 in the working age population - first results from a cohort study in Southern Sweden
Bjork, J., Inghammar, M., Moghaddassi, M., Rasmussen, M., Malmqvist, U., Kahn, F.
10.1101/2021.04.20.21254636 — Posted: 2021-04-21 Discussion: Onsite
Multifactorial SARS-CoV-2 seroprofiling dissects interdependencies with human coronaviruses and predicts neutralization activity
Abela, I. A., Pasin, C., Schwarzmueller, M., Epp, S., Sickmann, M., Schanz, M. M., Rusert, P., Weber, J., Schmutz, S., Audige, A., Maliqi, L., Hunziker, A., Hesselman, M. C., Niklaus, C. R., Gottschalk, J., Schindler, E., Wepf, A., Karrer, U., Wolfensberger, A., Rampini, S. K., Meyer Sauteur, P. M., Berger, C., Huber, M., Boeni, J., Braun, D. L., Marconato, M., Manz, M. G., Frey, B. M., Guenthard, H. F., Kouyos, R. D., Trkola, A.
10.1101/2021.04.21.21255410 — Posted: 2021-04-21

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).